open access
The relationship between anisocytosis, quantitative and qualitative characteristics of coronary atherosclerosis, and major adverse cardiac events in patients with coronary artery disease — rationale and study design
Affiliations- Department of Intensive Cardiac Therapy, National Institute of Cardiology, Warszawa, Poland
- Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, Warszawa, Poland
open access
Abstract
Abstract
About this articleTitle
The relationship between anisocytosis, quantitative and qualitative characteristics of coronary atherosclerosis, and major adverse cardiac events in patients with coronary artery disease — rationale and study design
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Short communication
Published online
2022-04-27
Page views
21
Article views/downloads
17
DOI
10.33963/KP.a2022.0111
Pubmed
Authors
Anna Oleksiak
Cezary Kępka
Mariusz Kruk
References (12)- Oleksiak A, Kruk M, et al. Biomarkers for risk stratification in secondary cardiovascular prevention. A role of red blood cell distribution width and calcium score . Atherosclerosis. 2016; 246: 57–62.
- Tonelli M, Sacks F, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008; 117(2): 163–168.
- Gul M, Uyarel H, et al. The relationship between red blood cell distribution width and the clinical outcomes in non-ST elevation myocardial infarction and unstable angina pectoris: a 3-year follow-up. Coron Artery Dis. 2012; 23(5): 330–336.
- Dabbah S, Hammerman H, et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol. 2010; 105(3): 312–317.
- Fatemi O, Paranilam J, Rainow A, et al. Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention. J Thromb Thrombolysis. 2013; 35(1): 57–64.
- Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007; 50(1): 40–47.
- Allen LA, Felker GM, Mehra MR, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010; 16(3): 230–238.
- Zhang Y, Wang Y, et al. Differences in the predictive value of red cell distribution width for the mortality of patients with heart failure due to various heart diseases. J Geriatr Cardiol. 2015; 12(6): 647–654.
- Förhécz Z, Gombos T, Borgulya G, et al. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009; 158(4): 659–666.
- Rostoff P, Siniarski A, Haberka M, et al. Relationship among the leptin-to-adiponectin ratio, systemic inflammation, and anisocytosis in well-controlled type 2 diabetic patients with atherosclerotic cardiovascular disease. Kardiol Pol. 2020; 78(5): 420–428.
- Veeranna V, Zalawadiya SK, et al. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multiethnic population: findings from the 1999-2004 NHANES. Int J Cardiol. 2013; 168(6): 5156–5161.
- Lappegård J, Ellingsen TS, Vik A, et al. Red cell distribution width and carotid atherosclerosis progression. The Tromsø Study. Thromb Haemost. 2015; 113(3): 649–654.
